PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $46,000 | -63.2% | 16,168 | -57.8% | 0.00% | – |
| Q4 2019 | $125,000 | +50.6% | 38,292 | -0.9% | 0.00% | – |
| Q3 2019 | $83,000 | -77.9% | 38,645 | -67.6% | 0.00% | – |
| Q2 2019 | $375,000 | -26.6% | 119,441 | -13.0% | 0.00% | -100.0% |
| Q1 2019 | $511,000 | -50.3% | 137,281 | -61.3% | 0.00% | 0.0% |
| Q4 2018 | $1,028,000 | +6.0% | 354,647 | -3.9% | 0.00% | 0.0% |
| Q3 2018 | $970,000 | -26.5% | 368,975 | -34.6% | 0.00% | 0.0% |
| Q2 2018 | $1,319,000 | -52.0% | 564,034 | -39.6% | 0.00% | -66.7% |
| Q1 2018 | $2,746,000 | +4.1% | 934,085 | -2.9% | 0.00% | +50.0% |
| Q4 2017 | $2,637,000 | -17.4% | 962,268 | +2.3% | 0.00% | -33.3% |
| Q3 2017 | $3,191,000 | +60.9% | 941,088 | +18.5% | 0.00% | +50.0% |
| Q2 2017 | $1,983,000 | +6.7% | 794,271 | -3.0% | 0.00% | 0.0% |
| Q1 2017 | $1,859,000 | +0.1% | 819,063 | -6.6% | 0.00% | 0.0% |
| Q4 2016 | $1,858,000 | +17.4% | 876,476 | +82.0% | 0.00% | 0.0% |
| Q3 2016 | $1,583,000 | +35.9% | 481,538 | +29.7% | 0.00% | +100.0% |
| Q2 2016 | $1,165,000 | +5.4% | 371,169 | +11.9% | 0.00% | 0.0% |
| Q1 2016 | $1,105,000 | +72.1% | 331,714 | +83.0% | 0.00% | 0.0% |
| Q4 2015 | $642,000 | -35.2% | 181,235 | -7.9% | 0.00% | 0.0% |
| Q3 2015 | $990,000 | -77.1% | 196,695 | -70.7% | 0.00% | -80.0% |
| Q2 2015 | $4,323,000 | -60.4% | 672,312 | -56.7% | 0.01% | -58.3% |
| Q1 2015 | $10,930,000 | -43.7% | 1,553,650 | -38.3% | 0.01% | -45.5% |
| Q4 2014 | $19,404,000 | +71.1% | 2,516,800 | +65.7% | 0.02% | +57.1% |
| Q3 2014 | $11,343,000 | -18.0% | 1,518,561 | +6.2% | 0.01% | -17.6% |
| Q2 2014 | $13,841,000 | +154.9% | 1,429,926 | +118.8% | 0.02% | +142.9% |
| Q1 2014 | $5,431,000 | -8.9% | 653,511 | -7.5% | 0.01% | -12.5% |
| Q4 2013 | $5,963,000 | +31.7% | 706,550 | +24.4% | 0.01% | +33.3% |
| Q3 2013 | $4,528,000 | +30.6% | 568,147 | +26.5% | 0.01% | +20.0% |
| Q2 2013 | $3,468,000 | – | 449,227 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |